FutureCure Health, a healthcare technology company, has raised INR 104 crore (around $11 million) in its Series C funding round, led by Carnelian Asset Management LLP along with other investors.
Earlier, in 2022, the company had raised $4 million from Kotak Alternate Asset Management, RVCF Ventures, and Unicorn India Ventures.
The new funding will be used to expand its clinic network, improve its digital platforms, and develop technology-based treatment models for long-term lifestyle diseases.
“This funding has reinforced our conviction that globally relevant healthcare technologies can be built in India. As we scale NeuroEquilibrium across hospitals in India and globally and expand into chronic lifestyle diseases such as migraine and diabetes, our focus is on using technology to bridge the shortage of specialist doctors. Precise, scalable diagnostics can democratise super-speciality healthcare and act as a true force multiplier for better outcomes,” said Rajneesh Bhandari, Founder, FutureCure Health.
Dr Anita Bhandari, Founder, FutureCure Health, said, “Vertigo/dizziness is often misdiagnosed, leaving patients untreated for years. Our work with 150,000+ patients proves that accurate diagnosis changes outcomes. This funding will help us take specialised vertigo care global.”
FutureCure was founded in 2015 by Rajneesh Bhandari and Anita Bhandari. It runs NeuroEquilibrium, a fully owned company that operates a chain of clinics focused on diagnosing and treating vertigo and dizziness.
Most treatments only give short-term relief. NeuroEquilibrium works differently — it tries to find the exact cause of vertigo, whether it comes from the inner ear, brain, or balance system, so patients get the right and long-lasting treatment.
There is a global shortage of specialized vertigo care. NeuroEquilibrium solves this by using advanced diagnostic tools, cloud-based remote systems, and deep technology to deliver accurate treatment not only in big cities, but also to patients across many parts of the world.
NeuroEquilibrium is expanding into more hospitals in India and other countries. It is also starting to work on long-term lifestyle diseases like migraine and diabetes.
The company uses technology to reduce its dependence on specialist doctors. Its scalable and accurate diagnostic system helps make specialized healthcare more accessible, affordable, and effective for more people.
Read More- FitXpert Raises Seven-Figure Funding to Expand Fitness & Nutrition SaaS Platform
